Combinatorial Extracellular Matrix Microenvironments for Probing Endothelial Differentiation of Human Pluripotent Stem Cells
Year: 2017
Type: article
Abstract: Endothelial cells derived from human pluripotent stem cells are a promising cell type for enhancing angiogenesis in ischemic cardiovascular tissues. However, our understanding of microenvironmental factors that modulate the process of endothelial differentiation is limited. We examined the role of combinatorial extracellular matrix (ECM) proteins on endothelial differentiation systematically using an arrayed microscale platform. Human pluripotent stem cells were differentiated on the arrayed ECM microenvironments for 5 days. Combinatorial ECMs composed of collagen IV + heparan sulfate + laminin (CHL) or collagen IV + gelatin + heparan sulfate (CGH) demonstrated significantly higher expression of CD31, compared to single-factor ECMs. These results were corroborated by fluorescence activated cell sorting showing a 48% yield of CD31 + /VE-cadherin + cells on CHL, compared to 27% on matrigel. To elucidate the signaling mechanism, a gene expression time course revealed that VE-cadherin and FLK1 were upregulated in a dynamically similar manner as integrin subunit β3 (>50 fold). To demonstrate the functional importance of integrin β3 in promoting endothelial differentiation, the addition of neutralization antibody inhibited endothelial differentiation on CHL-modified dishes by >50%. These data suggest that optimal combinatorial ECMs enhance endothelial differentiation, compared to many single-factor ECMs, in part through an integrin β3-mediated pathway.
Source: Scientific Reports
Authors: Luqia Hou, Joseph J. Kim, Maureen Wanjare, Bhagat Patlolla, John Coller, Vanita Natu, Trevor J. Hastie, Ngan F. Huang
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Awards: G1533673325, Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia, Spectrum Stanford Center for clinical and Translational Research and Education, Injectable Hydrogels to Improve the Efficacy of iPSC-derived Therapies, Matrix-mediated endothelial differentiation of induced pluripotent stem cells, Stanford Cancer Institute, G948357345
OpenAlex ID: W2736772103
